Comparative Immunohistochemical Analysis of IMP3, GLUT1, EMA, CD146, and Desmin for Distinguishing Malignant Mesothelioma From Reactive Mesothelial Cells
The DOI matches its Crossref record; 26 of the 27 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: To identify useful biomarkers for differentiating between malignant mesothelioma (MM) and reactive mesothelial cells (RMCs). METHODS: Formalin-fixed, paraffin-embedded (FFPE) tissues from 34 MM and 40 RMC samples were analyzed using immunohistochemistry, and the findings were compared. RESULTS: Positive markers for MM included insulin-like growth factor 2 messenger RNA binding protein 3 (IMP3), glucose transporter 1 (GLUT1), epithelial membrane antigen (EMA), and CD146, which showed sensitivities of 94%, 85%, 79%, and 71% and specificities of 78%, 100%, 88%, and 98%, respectively. In sarcomatoid MM, EMA had significantly lower expression than did IMP3, GLUT1, and CD146 (P < .001). The areas under receiver operating characteristic curves were the highest for IMP3 (0.95), followed by GLUT1 (0.93). When the optimal cutoff points for IMP3 (30%) and GLUT1 (10%) were used, the sensitivity of IMP3 and GLUT1 for MM was 100%, and the specificity of both for MM was 95%. CONCLUSIONS: The combination of IMP3 and GLUT1 is most appropriate for distinguishing MM from RMC using FFPE sections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It was demonstrated by Minato et al. that mesothelioma cells can upregulate GLUT-1 to uptake glucose more efficiently.”
From Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic Microenvironment in Malignant Mesothelioma (2023) · cites this paper as [117]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Increased levels of GLUT-1 are often correlated with poorer prognoses [117,118].”
From Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic Microenvironment in Malignant Mesothelioma (2023) · cites this paper as [117]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Advances in Malignant Mesothelioma
Robinson, B. W. S., & Lake, R. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050152 · Cited by 889 · cited 1×
“2,3,5-8,10,11,14 Those differences probably relate to differences in (1) study populations and the histology of the cases; (2) specimen types, such as exfoliated cells, cell blocks,”
BackgroundThe use of relative operating characteristic (ROC) curves in test performance evaluation.
Beck, & Shultz, E. K. (1986) · PubMed · Cited by 621
Structure, Function, and Regulation of the Mammalian Facilitative Glucose Transporter Gene Family
Olson, A. L., & Pessin, J. E. (1996) · Annual Review of Nutrition · doi:10.1146/annurev.nu.16.070196.001315 · Cited by 455
Structure, Function, and Regulation of the Mammalian Facilitative Glucose Transporter Gene Family
Olson, A. L. (1996) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.16.1.235 · Cited by 368
The Separation of Benign and Malignant Mesothelial Proliferations
(2000) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200009000-00001 · Cited by 272
Diagnostic importance of 9p21 homozygous deletion in malignant mesotheliomas
Chiosea, S., Krasinskas, A., Cagle, P. T., Mitchell, K. A., Zander, D. S., & Dacic, S. (2008) · Modern Pathology · doi:10.1038/modpathol.2008.45 · Cited by 207
Malignant Pleural Mesothelioma
Ray, M., & Kindler, H. L. (2009) · CHEST Journal · doi:10.1378/chest.08-2665 · Cited by 145
Kato, Y., Tsuta, K., Seki, K., Maeshima, A. M., WATANABE, S.-I. I., Suzuki, K., Asamura, H., Tsuchiya, R., & Matsuno, Y. (2006) · Modern Pathology · doi:10.1038/modpathol.3800732 · Cited by 140
Prognostic significance of p16/cdkn2a loss in pleural malignant mesotheliomas
Đačić, S., Kothmaier, H. E., Land, S. R., Shuai, Y., Halbwedl, I., Morbini, P., Murer, B., Comin, C., Galateau-Sallé, F., Demirağ, F., et al. (2008) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-008-0689-3 · Cited by 116
Monaco, S. E., Shuai, Y., Bansal, M., Krasinskas, A. M., & Dacic, S. (2011) · American Journal of Clinical Pathology · doi:10.1309/ajcpp5r2zjzkclwn · Cited by 116
Research works printed but not linked: 1
- Cury, 1999, The use of histological and immunohistochemical markers to distinguish pleural malignant mesothelioma and in situ mesothelioma from reactive mesothelial hyperplasia and reactive pleural fibrosis, J Pathol, 189, 251, 10.1002/(sici)1096-9896(199910)189:2<251::aid-path412>3.0.co;2-f · doi:10.1002/(sici)1096-9896(199910)189:2<251::aid-path412>3.0.co;2-f
Cited by
Cigognetti, M., Lonardi, S., Fisogni, S., Balzarini, P., Pellegrini, V., Tironi, A., Bercich, L., Bugatti, M., Rossi, G., Murer, B., et al. (2015) · Modern Pathology · doi:10.1038/modpathol.2015.65 · Cited by 306
New Markers for Separating Benign From Malignant Mesothelial Proliferations: Are We There Yet?
Churg, A., Sheffield, B. S., & Galateau-Salle, F. (2016) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2015-0240-sa · Cited by 156
“Reports that support or refute the specificity of EMA continue to be published.(6,7) We found that approximately 30% of patients with a diagnosis of atypical mesothelial hyperplasia and positive EMA staining were alive at 5 years after diagnosis.”
BackgroundKinoshita, Y., Hida, T., Hamasaki, M., Matsumoto, S., Sato, A., Tsujimura, T., Kawahara, K., Hiroshima, K., Oda, Y., & Nabeshima, K. (2017) · Cancer Cytopathology · doi:10.1002/cncy.21928 · Cited by 130
CD146 (Cluster of Differentiation 146): An Adhesion Molecule Involved in Vessel Homeostasis
Leroyer, A. S., Blin, M. G., Bachelier, R., Bardin, N., Blot‐Chabaud, M., & Dignat‐George, F. (2019) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.119.312653 · Cited by 118
Hjerpe, A., Ascoli, V., BEDROSSIAN, C. W. M., Boon, M. E., Creaney, J., Davidson, B., Dejmek, A., Dobra, K., Fassina, A., Field, A. S., et al. (2015) · CytoJournal · doi:10.4103/1742-6413.170726 · Cited by 98
“27-29] Furthermore, a general accumulation of p53 in cell tumor nuclei can in some cases be used as further supporting evidence of malignancy.”
Metadata
- Authors
- Minato, H., Kurose, N., Fukushima, M., Nojima, T., Usuda, K., Sagawa, M., Sakuma, T., Ooi, A., Matsumoto, I., Oda, M., Arano, Y., & Shimizu, J.
- Affiliations
- Kanazawa Medical University (JP)
- Kanazawa University (JP)
- KKR Hokuriku Hospital (JP)
- ORCID
- Venue
- American Journal of Clinical Pathology
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-01-01
- Volume
- 141
- Issue
- 1
- Pages
- 85-93
- ISSN
- 0002-9173 (ISSN-L)
- 1943-7722
- OpenAlex
- W2085588914
- Cited by
- 67
- References
- 27
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 2 · 2023: 4 · 2022: 2 · 2021: 5 · 2020: 8 · 2019: 9 · 2018: 11 · 2017: 5 · 2016: 5 · 2015: 9 · 2014: 2
- FWCI
- 4.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Clinical Pathology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Japan Society for the Promotion of Science (23590692, 25460452)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Health Sciences › Medicine › Surgery › Intraperitoneal and Appendiceal Malignancies
- Health Sciences › Medicine › Oncology › Sarcoma Diagnosis and Treatment
- Keywords
- malignant mesothelioma, reactive mesothelial cells, IGF2BP3, GLUT1, epithelial membrane antigen, CD146, desmin, diagnostic biomarkers, sarcomatoid mesothelioma, differential diagnosis, immunohistochemistry
- MeSH terms
- Mesothelioma, Malignant, Adolescent, Adult, Aged, Aged, 80 and over, Desmin, Epithelial Cells, Female, Humans, Immunohistochemistry, Lung Neoplasms, Male, Mesothelioma, Middle Aged, Biomarkers, Tumor, RNA-Binding Proteins, Mucin-1, Glucose Transporter Type 1, CD146 Antigen
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Comparative Immunohistochemical Analysis of IMP3, GLUT1, EMA, CD146, and Desmin for Distinguishing Malignant Mesothelioma From Reactive Mesothelial Cells. https://app.cochat.ai/papers/10.1309/ajcp5knl7qtellyi
- The paper
- Minato, H., Kurose, N., Fukushima, M., Nojima, T., Usuda, K., Sagawa, M., Sakuma, T., Ooi, A., Matsumoto, I., Oda, M., Arano, Y., & Shimizu, J. (2014). Comparative Immunohistochemical Analysis of IMP3, GLUT1, EMA, CD146, and Desmin for Distinguishing Malignant Mesothelioma From Reactive Mesothelial Cells. American Journal of Clinical Pathology. https://doi.org/10.1309/ajcp5knl7qtellyi
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.